Landiolol, a new ultra-short-acting β1-blocker, reduces anaesthetic requirement during sevoflurane/N2O/fentanyl anaesthesia in surgical patients

European Journal of Anaesthesiology

Volumn 26, Issue 1, 2009, Pages 39-42

  Tanabe, Takahiro ^a   Fukusaki, Makoto ^a   Fujinaga, Arihiro ^a   Ando, Yuko ^a   Yamashita, Kazunori ^a   Terao, Yoshiaki ^a   Sumikawa, Koji ^b  

^a NAGASAKI ROSAI HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenergic beta antagonists; Anaesthesia inhalational; Landiolol; Sevoflurane

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FENTANYL; LANDIOLOL; NITROUS OXIDE; SEVOFLURANE; SODIUM CHLORIDE; ANESTHETIC AGENT; DRUG DERIVATIVE; ETHER DERIVATIVE; MORPHOLINE DERIVATIVE; UREA;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BISPECTRAL INDEX; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; FEMALE; HEART RATE; HEMODYNAMICS; HIP SURGERY; HUMAN; INHALATION ANESTHESIA; INTRAOPERATIVE PERIOD; LOW DRUG DOSE; MALE; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; SYSTOLIC BLOOD PRESSURE; ANESTHESIA; HIP; METHODOLOGY; MIDDLE AGED; TIME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANESTHESIA; ANESTHETICS; FEMALE; FENTANYL; HIP; HUMANS; MALE; METHYL ETHERS; MIDDLE AGED; MORPHOLINES; NITROUS OXIDE; TIME FACTORS; UREA;

EID: 64849113673     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328318c6a9     Document Type: Article

References (25)

1. Miller DR, Martineau RJ, Wynands JE, Hill J. Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: the Canadian multicentre trial. Can J Anaesth 1991; 38: 849-858.
2. Gold JI, Sacks DJ, Grosnoff DB, et al. Use of esmolol during anaesthesia to treat tachycardia and hypertension. Anesth Analg 1989; 68: 101 -104.
3. Fuhrman TM, Ewell CL, Pippin WD, Weaver JM. Comparison of the efficacy of esmolol and alfentanil to attenuate the hemodynamic responses to emergence and extubation. J Clin Anesth 1992; 4: 444-447.
4. Leslie JB. Bolus dose esmolol for anaesthesia: is there a need? J Clin Anesth 1990; 2: 215-220.
5. Johansen JW, Flaishon R, Sebel PS. Esmolol reduces anaesthetic requirement for skin incision during propofol/nitrous oxide/morphine anaesthesia. Anesthesiology 1997; 86: 364-371.
6. Johansen JW, Schneider G, Windsor AM, Sebel PS. Esmolol potentiates reduction of minimal alveolar isoflurane concentration by alfentanil. Anesth Analg 1998; 87: 671 -676.
7. Coloma M, Chiu JW, White PF, Armbruster SC. The use of esmolol as an alternative to remifentanil during desflurane anaesthesia for fast-tract outpatient gynecologic laparoscopic surgery. Anesth Analg 2001; 92: 352-357. (Pubitemid 32127617)
8. Chia YY, Chan MH, Ko NH, Liu K. Role of (beta)-blockade in anaesthesia and postoperative pain management after hysterectomy. Br J Anaesth 2004; 93: 799 -805.
9. Menigaux C, Guignard B, Adam F, et al. Esmolol prevents movement and attenuates the BIS response to orotracheal intubation. BrJAnaesth 2002; 89: 857-862.
10. Oda Y, Nishikawa K, Hase I, Asada A. The short-acting {beta} 1- adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anaesthesia. Anesth Analg 2005; 100: 733-737.
11. Iguchi S, Iwamura H, Nishizaki M, et al. Development of a highly cardioselective ultra short-acting fl-blocker, ONO-1101. Chem Pharm Bull 1992; 40: 1462 -1469.
12. Kurita T, Morita K, Fukuda K, et al. Landiolol, an ultra-short-acting beta 1-adrenoceptor antagonist, does not alter the electroencephalographic effect of isoflurane in swine model. Br J Anaesth 2006; 96: 602-607.
13. Kurita T, Takata K, Uraoka M, et al. Landiolol, an ultra short-acting beta1- adrenoceptor antagonist, does not alter the minimum alveolar anaesthetic concentration of isoflurane in a swine model. Anesth Analg 2007; 105: 656-660.
14. Fragen RJ, Dunn KL. The minimum alveolar concentration (MAC) of sevoflurane with and without nitrous oxide in elderly versus young adults. J Clin Anesth 1996; 8: 352-356.
15. 1 blocker ONO-1101 (3): metabolism and protein binding [in Japanese]. Xenobio Metab Dispos 1997; 12: 31 -41 [English abstract].
16. Nakashima M, Kanamaru M. Phase I study of ONO-1101, a new ultra short acting brblocking agent in healthy volunteers [in Japanese]. Rinsho lyaku 2000; 16: 1531-2155 [English abstract].
17. Yoshiya I, Ogawa R, Okumura F, et al. Clinical evaluation of landiolol hydrochloride (ONO-1101) on perioperative supraventricular tachyarrhythmia: a double-blind, dose finding study [in Japanese]. Rinsho lyaku 1997; 13: 4949-4978 [English abstract].
18. Berridge CW, Foote SL. Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic β-receptors within the medial septal region of the basal forebrain. J Neurosci 1996; 16: 6999 -7009.
19. Johnson IA, Andrzejowski J, Sikiotis L. Arousal following isoprenaline. Anaesth Intensive Care 1999; 27: 221.
20. Andrzejowski J, Sleigh JW, Johnson IAT, Sikiotis L. The effect ofintravenous epinephrine on the bispectral index and sedation. Anaesthesia 2000; 55: 761 -763.
21. 1 blocker ONO-1101 (1) plasma concentration-time profile, distribution and excretion after single intravenous administration to rats. Yakubutudoutai 1997; 12: 5-21.
22. Rampil IJ. A primer for EEG signal processing in anaesthesia. Anesthesiology 1998; 89: 980-1002.
23. Johansen JW, Sebel PS, Sigl JC. Clinical impact of hypnotic titration guidelines based on EEG bispectral index (BIS) monitoring during routine anaesthetic care. J Clin Anesth 2000; 12: 433-443.
24. Pavlin DJ, Hong JY, Freund PR, et al. The effect of bispectral index monitoring on end-tidal gas concentration and recovery duration after outpatient anaesthesia. Anesth Analg 2001; 93: 613-619.
25. Wong J, Song D, Blansbard H, et al. Titration of isoflurane using BIS index improves early recovery of elderly patients undergoing orthopedic surgeries. Can J Anaesth 2002; 49: 13-18.